13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 105 holding rows worth $4,513,577,000.
- Accession
- 0001791827-21-000006
- Filer
- CIK 1791827
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 105 entries on the cover page, a total value of $4,513,577,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,513,577,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 3,021,000 | $379,770,000 | thousands by filing date | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,228,100 | $211,356,000 | thousands by filing date | call |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,062,400 | $187,949,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 2,234,700 | $183,648,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 1,613,200 | $174,016,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 926,400 | $168,040,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 2,493,800 | $166,187,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 3,247,700 | $132,831,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 934,200 | $129,770,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 4,823,400 | $92,175,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 152,300 | $92,169,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 537,000 | $91,183,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 826,000 | $90,480,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 832,000 | $85,538,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 1,412,000 | $84,805,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 848,900 | $81,418,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 427,000 | $80,622,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 330,000 | $76,247,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 7,263,488 | $72,199,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 638,700 | $71,177,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 945,400 | $69,780,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 862,000 | $69,331,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 1,139,000 | $67,827,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 4,100,000 | $66,584,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 351,000 | $64,788,000 | thousands by filing date | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 2,541,893 | $64,335,000 | thousands by filing date | |
| SOTERA HEALTH CO | 83601L102 | COM | 2,378,000 | $62,185,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,437,000 | $62,119,000 | thousands by filing date | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 2,474,067 | $59,056,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 398,000 | $52,962,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 4,457,831 | $48,145,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 894,000 | $45,201,000 | thousands by filing date | |
| ORTHO CLINICAL DIAGNOSTICS H | G6829J107 | ORD SHS | 2,398,000 | $44,315,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 1,026,800 | $44,163,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 673,700 | $42,059,000 | thousands by filing date | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 2,025,000 | $41,270,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 455,000 | $41,036,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,095,600 | $40,614,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,645,000 | $40,516,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,462,200 | $36,058,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,292,000 | $35,582,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 369,000 | $35,221,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,162,000 | $34,709,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 2,786,000 | $33,961,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 251,000 | $33,672,000 | thousands by filing date | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 454,000 | $32,910,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 1,943,000 | $30,563,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 4,942,000 | $30,344,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 514,500 | $30,222,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 1,683,441 | $29,544,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 2,167,900 | $24,519,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 515,000 | $22,413,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,932,000 | $20,614,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,450,000 | $19,600,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 2,419,600 | $18,970,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 739,269 | $18,600,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 831,200 | $17,804,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 774,644 | $17,445,000 | thousands by filing date | |
| UIPATH INC | 90364P105 | CL A | 319,000 | $16,783,000 | thousands by filing date | |
| FIELD TRIP HEALTH LTD | 31656R102 | COM | 3,581,000 | $16,437,000 | thousands by filing date | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 1,000,000 | $14,500,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 4,405,000 | $13,700,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 1,660,000 | $12,599,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 560,000 | $12,354,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 748,995 | $12,276,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 1,739,600 | $11,673,000 | thousands by filing date | |
| SCYNEXIS INC | 811292200 | COM NEW | 2,060,000 | $10,918,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 625,120 | $10,727,000 | thousands by filing date | |
| SENTINELONE INC | 81730H109 | CL A | 200,000 | $10,714,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 1,190,600 | $9,406,000 | thousands by filing date | |
| ENGAGESMART INC | 29283F103 | COMMON STOCK | 275,000 | $9,367,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 550,000 | $9,136,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 3,836,798 | $8,825,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 827,402 | $7,993,000 | thousands by filing date | |
| ZETA GLOBAL HOLDINGS CORP CL A | 98956A105 | Stock | 1,300,000 | $7,618,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 408,140 | $7,296,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 300,000 | $6,684,000 | thousands by filing date | |
| ONCOSEC MED INC | 68234L306 | COM | 2,945,000 | $6,273,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 455,000 | $6,170,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 35,000 | $6,024,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 145,100 | $5,740,000 | thousands by filing date | |
| ZIOPHARM ONCOLOGY INC | 98973P101 | COM | 3,000,000 | $5,460,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 520,000 | $5,070,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 500,000 | $5,025,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 500,000 | $4,980,000 | thousands by filing date | |
| DYNAMICS SPECIAL PURPOSE COR | 268010105 | CLASS A COM | 500,000 | $4,970,000 | thousands by filing date | |
| HEALTHCOR CATALIO ACQU CORP | G44125105 | CL A SHS | 500,000 | $4,950,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 500,000 | $4,885,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 330,000 | $4,089,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 400,000 | $3,956,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 400,000 | $3,940,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 400,000 | $3,920,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 300,000 | $3,879,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 35,600 | $3,752,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 600,000 | $3,684,000 | thousands by filing date | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 145,189 | $3,296,000 | thousands by filing date | |
| ATAIBECKLEY INC | N0731H103 | Equity | 218,730 | $3,235,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 260,000 | $2,246,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLDS CRP | G8253T106 | CLASS A ORD SHS | 200,000 | $1,990,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLDS CRP | G8253U103 | CMN | 200,000 | $1,976,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLDS CP | G8253Y105 | CLASS A ORD SHS | 200,000 | $1,962,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLD CRPI | G8253W109 | CMN | 200,000 | $1,960,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 99,999 | $253,000 | thousands by filing date | |
| SOMALOGIC INC | 83444k113 | WT | 65,999 | $228,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 57,770 | $41,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-21-000006 | this filing | 2021-11-15 | acceptance time not in the bulk data set |